To date, Raven has raised more than $66 million of equity capital.

Institutional Investors

• Bear Stearns Health Innoventures (BSHI)
• CMEA Ventures
• Cogene Biotech Ventures
• GE Life Science and Technology Finance Group
• Hambrecht & Quist Capital Management
• Integra Ventures
• Pequot Ventures
• Saints VC
• U.S. Venture Partners
• Vulcan Capital